Top & Current
Thu, August 8, 2024
[ Thu, Aug 08th 2024
] - WOPRAI
[ Thu, Aug 08th 2024
] - WOPRAI
Thu, July 25, 2024
[ Thu, Jul 25th 2024
] - WOPRAI
Wed, June 26, 2024
[ Wed, Jun 26th 2024
] - WOPRAI
Fri, May 10, 2024
[ Fri, May 10th 2024
] - WOPRAI
Thu, May 9, 2024
[ Thu, May 09th 2024
] - WOPRAI
Tue, May 7, 2024
[ Tue, May 07th 2024
] - WOPRAI
Tue, March 26, 2024
[ Tue, Mar 26th 2024
] - WOPRAI
Tue, March 12, 2024
[ Tue, Mar 12th 2024
] - WOPRAI
Thu, March 7, 2024
[ Thu, Mar 07th 2024
] - WOPRAI
Thu, February 29, 2024
[ Thu, Feb 29th 2024
] - WOPRAI
Thu, January 4, 2024
[ Thu, Jan 04th 2024
] - WOPRAI
Wed, December 13, 2023
[ Wed, Dec 13th 2023
] - WOPRAI
[ Wed, Dec 13th 2023
] - WOPRAI
[ Wed, Dec 13th 2023
] - WOPRAI
Wed, April 26, 2023
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
[ Wed, Apr 26th 2023
] - WOPRAI
David Hoang Maintained (SRPT) at Hold with Decreased Target to $160 on, Aug 8th, 2024
David Hoang of Citigroup, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Decreased Target from $176 to $160 on, Aug 8th, 2024.
David has made no other calls on SRPT in the last 4 months.
There are 9 other peers that have a rating on SRPT. Out of the 9 peers that are also analyzing SRPT, 0 agree with David's Rating of Hold.
These are the ratings of the 9 analyists that currently disagree with David
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $235 on, Thursday, June 27th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Mani Foroohar of "Leerink Partners" Maintained at Buy with Increased Target to $230 on, Monday, June 24th, 2024
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Monday, June 24th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $213 on, Friday, June 21st, 2024
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $200 on, Friday, June 21st, 2024
- Uy Ear of "Mizuho" Maintained at Strong Buy with Increased Target to $179 on, Friday, May 17th, 2024
- Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Tuesday, May 14th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $175 on, Friday, May 3rd, 2024